Adjuvant treatment for early-stage endometrial cancer

Israel Zighelboim, Matthew A. Powell

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


A subgroup of endometrial cancer patients with early-stage disease will progress or eventually present with recurrent disease. Multiple risk stratification strategies have been attempted to direct adjuvant therapeutic interventions. Radiation has been the most common form of adjuvant therapy offered to these patients. Unfortunately, its use has not translated into survival improvements. There is growing evidence supporting the use of adjuvant chemotherapy and multimodal interventions for patients with endometrial cancer. This review focuses on the role of adjuvant therapies for patients with early-stage disease with emphasis on future directions for risk stratification and personalized treatment.

Original languageEnglish
Pages (from-to)245-255
Number of pages11
JournalClinical Obstetrics and Gynecology
Issue number2
StatePublished - Jun 1 2011


  • Endometrial cancer
  • adjuvant
  • biologic therapy
  • chemotherapy
  • early stage
  • radiotherapy

Fingerprint Dive into the research topics of 'Adjuvant treatment for early-stage endometrial cancer'. Together they form a unique fingerprint.

Cite this